Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon C Jayson

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
Cancer Science|April 11, 2007
Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinomaShirley Ralph, Paul E C Brenchley, Angela Summers, et al.
Biochemical Society Transactions|November 18, 2014
The development of anti-angiogenic heparan sulfate oligosaccharidesGordon C Jayson, Gavin J Miller, Steen U Hansen, et al.
Organic & Biomolecular Chemistry|September 19, 2015
A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharidesGavin J Miller, Karl R Broberg, Claire Rudd, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 12, 2011
DCE-MRI model selection for investigating disruption of microvascular function in livers with metastatic diseaseAnita Banerji, Josephine H Naish, Yvonne Watson, et al.
Molecules (Basel, Switzerland)|April 11, 2015
Modular synthesis of heparin-related tetra-, hexa- and octasaccharides with differential o-6 protections: programming for regiodefined 6-o-modificationsMarek Baráth, Steen U Hansen, Charlotte E Dalton, et al.
Nature Communications|July 6, 2013
Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studiesSteen U Hansen, Gavin J Miller, Claire Cole, et al.
Plos One|July 27, 2010
Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesisClaire L Cole, Steen U Hansen, Marek Baráth, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian CancerRobert D Morgan, Andrew R Clamp, Jurjees Hasan, et al.
Gynecologic Oncology|April 9, 2018
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancerJoyce Liu, Shibani Nicum, Peter Reichardt, et al.
The Lancet. Oncology|August 2, 2008
Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectivesJames P B O'Connor, Alan Jackson, Marie-Claude Asselin, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Cancer Science|April 11, 2007
Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinomaShirley Ralph, Paul E C Brenchley, Angela Summers, et al.
Biochemical Society Transactions|November 18, 2014
The development of anti-angiogenic heparan sulfate oligosaccharidesGordon C Jayson, Gavin J Miller, Steen U Hansen, et al.
Organic & Biomolecular Chemistry|September 19, 2015
A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharidesGavin J Miller, Karl R Broberg, Claire Rudd, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 12, 2011
DCE-MRI model selection for investigating disruption of microvascular function in livers with metastatic diseaseAnita Banerji, Josephine H Naish, Yvonne Watson, et al.
Molecules (Basel, Switzerland)|April 11, 2015
Modular synthesis of heparin-related tetra-, hexa- and octasaccharides with differential o-6 protections: programming for regiodefined 6-o-modificationsMarek Baráth, Steen U Hansen, Charlotte E Dalton, et al.
Nature Communications|July 6, 2013
Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studiesSteen U Hansen, Gavin J Miller, Claire Cole, et al.
Plos One|July 27, 2010
Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesisClaire L Cole, Steen U Hansen, Marek Baráth, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian CancerRobert D Morgan, Andrew R Clamp, Jurjees Hasan, et al.
Gynecologic Oncology|April 9, 2018
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancerJoyce Liu, Shibani Nicum, Peter Reichardt, et al.
The Lancet. Oncology|August 2, 2008
Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectivesJames P B O'Connor, Alan Jackson, Marie-Claude Asselin, et al.
Pageof 13